How much does generic entrectinib cost?

Entrectinib is a targeted therapy drug used to treat certain types of cancer, especially NTRK gene fusion-positive tumors and ROS1-positive non-small cell lung cancer. The drug is designed to target specific proteins in tumor cells, thereby inhibiting their growth and spread, providing patients with a new treatment option.

Entrectinib is now on the market in China and has been successfully included in the medical insurance system. Domestic patients can purchase it directly. However, its price is quite expensive, with a cost of about 20,000 yuan. For detailed information on specific prices and medical insurance reimbursement, please consult your local hospital pharmacy for accurate answers.

In comparison, the price of generic entrectinib drugs in foreign markets is more affordable, especially the generic drugs in Laos, which cost only about one to two thousand yuan, and their drug ingredients are basically the same as the original drugs. Therefore, patients can reasonably choose purchasing channels based on their own financial status and treatment needs.

NTRK gene fusions and abnormal expression of ROS1 proteins are common in certain cancer types, and these abnormalities can lead to abnormal proliferation and growth of tumor cells. By inhibiting the activity of these abnormal proteins, entrectinib prevents the growth and spread of tumor cells, helping to slow the progression of the disease and improve patient survival rates.

Compared with traditional chemotherapy drugs, entrectinib has higher selectivity, fewer toxic side effects, and can target tumor cells more effectively. This makes it an important treatment option, especially for patients who cannot receive or tolerate traditional chemotherapy, offering hope and new opportunities.

Clinical trials have shown that entrectinib has significant efficacy in the treatment of NTRK gene fusion-positive tumors and ROS1-positive non-small cell lung cancer. In these trials, entrectinib was shown to be effective in controlling tumor growth and, in some cases, even leading to complete tumor regression.